GALT · ISSUER CIK 1133416
GALECTIN THERAPEUTICS INC
Between Aug 1, 2026 and Oct 29, 2026, 1 GALECTIN THERAPEUTICS INC insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Aug 4, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 4, 202607:52 | Jul 31, 2026 | GALT | Director, 10% Owner | M · Exercise | $3.08 | +34,376,167 | 44,713,843 | +333% | $105.8M |